These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Advances in immunotherapeutic research for glioma therapy. Miyauchi JT; Tsirka SE J Neurol; 2018 Apr; 265(4):741-756. PubMed ID: 29209782 [TBL] [Abstract][Full Text] [Related]
43. Active immunotherapy: oncolytic virus therapy using HSV-1. Todo T Adv Exp Med Biol; 2012; 746():178-86. PubMed ID: 22639168 [TBL] [Abstract][Full Text] [Related]
44. Oncolytic measles virus strains in the treatment of gliomas. Allen C; Paraskevakou G; Liu C; Iankov ID; Msaouel P; Zollman P; Myers R; Peng KW; Russell SJ; Galanis E Expert Opin Biol Ther; 2008 Feb; 8(2):213-20. PubMed ID: 18194077 [TBL] [Abstract][Full Text] [Related]
45. Immunotherapy targeting glioma stem cells--insights and perspectives. Li Z; Lee JW; Mukherjee D; Ji J; Jeswani SP; Black KL; Yu JS Expert Opin Biol Ther; 2012 Feb; 12(2):165-78. PubMed ID: 22200324 [TBL] [Abstract][Full Text] [Related]
54. MicroRNA-Attenuated Clone of Virulent Semliki Forest Virus Overcomes Antiviral Type I Interferon in Resistant Mouse CT-2A Glioma. Martikainen M; Niittykoski M; von und zu Fraunberg M; Immonen A; Koponen S; van Geenen M; Vähä-Koskela M; Ylösmäki E; Jääskeläinen JE; Saksela K; Hinkkanen A J Virol; 2015 Oct; 89(20):10637-47. PubMed ID: 26269187 [TBL] [Abstract][Full Text] [Related]
55. Biological intratumoral therapy for the high-grade glioma part II: vector- and cell-based therapies and radioimmunotherapy. Loya J; Zhang C; Cox E; Achrol AS; Kesari S CNS Oncol; 2019 Nov; 8(3):CNS40. PubMed ID: 31747784 [TBL] [Abstract][Full Text] [Related]
56. Oncolytic viral therapy and immunotherapy of malignant brain tumors: two potential new approaches of translational research. Lou E Ann Med; 2004; 36(1):2-8. PubMed ID: 15000342 [TBL] [Abstract][Full Text] [Related]
57. Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas. Zhang Q; Xiang W; Yi DY; Xue BZ; Wen WW; Abdelmaksoud A; Xiong NX; Jiang XB; Zhao HY; Fu P Stem Cell Res Ther; 2018 Aug; 9(1):228. PubMed ID: 30143053 [TBL] [Abstract][Full Text] [Related]
58. Peptide vaccine. Izumoto S Adv Exp Med Biol; 2012; 746():166-77. PubMed ID: 22639167 [TBL] [Abstract][Full Text] [Related]